Safety of a 2-visit cluster schedule of venom immunotherapy in outpatients at risk of life-threatening anaphylaxis

Journal of Investigational Allergology and Clinical Immunology

Volumn 20, Issue 1, 2010, Pages 91-92

  Sanchez Machin I ^a   Moreno, C ^b   Gonzalez R ^a   Iglesias Souto, J ^a   Perez E ^a   Matheu, Victor ^a,c  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Anaphylaxis; Honeybee; Insect allergy; Venom immunotherapy

Indexed keywords

BEE VENOM; IMMUNOGLOBULIN E; PHARMALGEN;

ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; ARTICLE; BEE STING; CHILD; DRUG DOSE INCREASE; DRUG SAFETY; FEMALE; HONEYBEE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; INSECT ALLERGY; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRICK TEST; RISK ASSESSMENT; SCHOOL CHILD; URTICARIA;

ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; BEE VENOMS; CHILD; DESENSITIZATION, IMMUNOLOGIC; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; RISK;

EID: 77249177074     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Bilo BM, Bonifazi F. Epidemiology of insect-venom anaphylaxis. Curr Opin Allergy Clin Immunol. 2008;8:330-7.
2. Golden DBK. Insect allergy; in Adkinson NF, Brochner, BS, Busse, WW, Holgate, ST, Lemanske, RF, Simons, FER. (ed Middleton's Allergy, 7th edition: Principles and practice, Elsevier Inc., 2009, vol 2, pp. 1005-17.
3. Bernstein JA, Kagen SL, Bernstein DI, Bernstein IL. Rapid venom immunotherapy is safe for routine use in the treatment of patients with hymenoptera anaphylaxis. Ann Allergy. 1994;73:423-8.
4. Moreno C, Cuesta-Herranz J, Fernandez-Tavora L, Alvarez-Cuesta E. Immunotherapy safety: A prospective multi-centric monitoring study of biologically standardized therapeutic vaccines for allergic diseases. Clin Exp Allergy. 2004;34:527-31.
5. Parmiani S, Fernandez Tavora L, Moreno C, Guardia P, Rico P. Clustered schedules in allergen-specific immunotherapy. Allergol Immunopathol (Madr) 2002;30:283-91.
6. Cox L. Accelerated immunotherapy schedules: Review of efficacy and safety. Ann Allergy Asthma Immunol. 2006;97:126-37; quiz 137-40, 202.
7. Wuthrich B. Classification of sting insect sensitivity. J Investig Allergol Clin Immunol. 2001;11:132.
8. Golden DB, Kagey-Sobotka A, Norman PS, Hamilton RG, Lichtenstein LM. Insect sting allergy with negative venom skin test responses. J Allergy Clin Immunol. 2001;107:897-901.
9. Rueff F, Przybilla B. Venom immunotherapy. Side effects and efficacy of treatment. Hautarzt. 2008;59:200-5.